News
-
-
-
-
-
-
PRESS RELEASE
Newron Provides Update on FDA Clinical Hold and Phase 3 ENIGMA-TRS Development Program
Newron Pharmaceuticals provides update on FDA Clinical Hold and Phase 3 ENIGMA-TRS development program, reviewing feedback and preparing response. ENIGMA-TRS 1 enrollment completion by mid-October, 12-week data expected Q1 2027 -
PRESS RELEASE
Press release: Ground-breaking ceremony for 122 apartments in the Nordbau
Mobimo holds ground-breaking ceremony for 122 apartments in the Nordbau, Aarau, part of the final expansion phase of the Aeschbachquartier, combining industrial history with contemporary living, sustainable features included -
-
-